Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Dunn

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Archives of Dermatology|July 20, 2011
Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunityShane E Cotter, Gavin P Dunn, Kristina M Collins, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 15, 2015
Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-upEric J Arias, Gavin P Dunn, Chad W Washington, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Cancer Discovery|September 30, 2016
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade ImmunotherapyTanner M Johanns, Christopher A Miller, Ian G Dorward, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Oncotarget|February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinomaPaul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Cancer Immunology Research|November 2, 2016
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics ApproachTanner M Johanns, Jeffrey P Ward, Christopher A Miller, et al.
Theranostics|January 6, 2022
Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNAChristopher P Pacia, Jinyun Yuan, Yimei Yue, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 30, 2023
A pilot study of lymphoscintigraphy with tracer injection into the human brainAndrew T Coxon, Rupen Desai, Pujan R Patel, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Archives of Dermatology|July 20, 2011
Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunityShane E Cotter, Gavin P Dunn, Kristina M Collins, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 15, 2015
Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-upEric J Arias, Gavin P Dunn, Chad W Washington, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Nature Immunology|June 14, 2005
A critical function for type I interferons in cancer immunoeditingGavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, et al.
Cancer Discovery|September 30, 2016
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade ImmunotherapyTanner M Johanns, Christopher A Miller, Ian G Dorward, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Oncotarget|February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinomaPaul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Cancer Immunology Research|November 2, 2016
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics ApproachTanner M Johanns, Jeffrey P Ward, Christopher A Miller, et al.
Theranostics|January 6, 2022
Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNAChristopher P Pacia, Jinyun Yuan, Yimei Yue, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 30, 2023
A pilot study of lymphoscintigraphy with tracer injection into the human brainAndrew T Coxon, Rupen Desai, Pujan R Patel, et al.
Pageof 15